Home › NDC Lookup › RxCUI directory › RxCUI 1053852

Acetaminophen 500 MG / pamabrom 25 MG / pyrilamine maleate 15 MG Oral Tablet [Pamprin Mult... — RxCUI 1053852

RxNorm drug concept · Semantic branded drug
RxCUI 1053852 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1053852
Official nameAcetaminophen 500 MG / pamabrom 25 MG / pyrilamine maleate 15 MG Oral Tablet [Pamprin Multi-Symptom]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asAPAP 500 MG / pamabrom 25 MG / Pyrilamine Maleate 15 MG Oral Tablet [Pamprin Multi-Symptom]; Pamprin Max Strength Multi-Symptom 500 MG / 25 MG / 15 MG Oral Tablet
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Acetaminophen Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats mild to moderate pain, and moderate to severe pain when used with opioid medicines. It also lowers fever. It is given through a vein in a healthcare setting.
  • What is Acetaminophen Injection used for?
  • It is given as an IV infusion over 15 minutes by a healthcare professional. Your dose depends on your age and weight. Your care team follows the label and your prescriber's orders.
  • The most common are nausea and vomiting. Adults may also get headache or trouble sleeping. Children may have constipation or itching.
📖 Read our full Acetaminophen Injection guide →

🕸️ Concept Web — How Acetaminophen 500 MG / pamabrom 25 MG / pyrilami... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Acetaminophen 500 MG / pamabrom 25 MG / pyrilamine maleate 15 MG Oral Tablet [Pamprin Multi-Symptom] RxCUI 1053852

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 5

    The active substance itself — no strength, form, or brand attached yet.

    • Acetaminophen 161
    • Pamabrom 54365
    • Pyrilamine 9009
    • Acetaminophen / pamabrom / pyrilamine 214156
    • Pyrilamine maleate 82091
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Pamprin Multi-Symptom 1052436
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Acetaminophen / pamabrom / pyrilamine Oral Tablet 379004
    • Acetaminophen / pamabrom / pyrilamine maleate Oral Tablet 2647897
    • Acetaminophen / pamabrom / pyrilamine Oral Product 1152545
    • Acetaminophen / pamabrom / pyrilamine Pill 1152546
    • Acetaminophen / pamabrom / pyrilamine maleate Oral Product 2662301
    • Acetaminophen / pamabrom / pyrilamine maleate Pill 2659904
    • Acetaminophen / pamabrom / pyrilamine Oral Tablet [Pamprin Multi-Symptom] 1052438
    • Acetaminophen / pamabrom / pyrilamine maleate Oral Tablet [Pamprin Multi-Symptom] 2654637
    • +5 more in this family
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 19 of 24 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Acetaminophen 500 MG / pamabrom 25 MG / pyrilamine maleate 15 MG Oral Tablet SCD · 1052637
  • Acetaminophen 500 MG SCDC · 315266
  • Pamabrom 25 MG SCDC · 316430
  • Pyrilamine maleate 15 MG SCDC · 1052636
  • Acetaminophen / pamabrom / pyrilamine Oral Tablet SCDF · 379004
  • Acetaminophen / pamabrom / pyrilamine maleate Oral Tablet SCDFP · 2647897
  • Acetaminophen / pamabrom / pyrilamine Oral Product SCDG · 1152545
  • Acetaminophen / pamabrom / pyrilamine Pill SCDG · 1152546
  • Acetaminophen / pamabrom / pyrilamine maleate Oral Product SCDGP · 2662301
  • Acetaminophen / pamabrom / pyrilamine maleate Pill SCDGP · 2659904

Brand-Name Concepts

  • Acetaminophen 500 MG / pamabrom 25 MG / pyrilamine maleate 15 MG [Pamprin Multi-Symptom] SBDC · 1053851
  • Acetaminophen / pamabrom / pyrilamine Oral Tablet [Pamprin Multi-Symptom] SBDF · 1052438
  • Acetaminophen / pamabrom / pyrilamine maleate Oral Tablet [Pamprin Multi-Symptom] SBDFP · 2654637
  • Pamprin Multi-Symptom Oral Product SBDG · 1179907
  • Pamprin Multi-Symptom Pill SBDG · 1179908
  • Pamprin Multi-Symptom BN · 1052436

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 1053852 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
71687-3003-01 1 BOTTLE, PLASTIC in 1 CARTON (71687-3003-1) / 20 TABLET in... Pamprin Multi-Symptom Maximum Strength Focus Consumer Healthcare, LLC 2016-06-01
71687-3003-04 1 BOTTLE, PLASTIC in 1 CARTON (71687-3003-4) / 40 TABLET in... Pamprin Multi-Symptom Maximum Strength Focus Consumer Healthcare, LLC 2016-06-01
Observed labelers: Focus Consumer Healthcare, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.